On December 27, 2023, Thomas Crockett, CEO of KalVista Pharmaceuticals Inc (KALV), sold 30,000 shares of the company's stock, according to a recent SEC Filing.
Read full NASCAR article on Yahoo Sports
Read all NASCAR articles
On December 27, 2023, Thomas Crockett, CEO of KalVista Pharmaceuticals Inc (KALV), sold 30,000 shares of the company's stock, according to a recent SEC Filing.
Read full NASCAR article on Yahoo Sports
Read all NASCAR articles